Decheng Capital Global Life Sciences Fund IV, L.P.

CIK 1834150 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Decheng Capital Global Life Sciences Fund IV, L.P..

Recent SEC filings

FiledFormAccession number
May 15, 2026SCHEDULE 13G/A0001834150-26-000003
Feb 24, 2025SCHEDULE 13G0001415889-25-005246
Feb 19, 202540000950170-25-023409
Feb 14, 2025SCHEDULE 13G/A0001415889-25-004201
Feb 14, 2025SCHEDULE 13G0001415889-25-004199
Feb 12, 202530000950170-25-019187
Apr 9, 20244/A0001415889-24-010609
Apr 9, 2024SC 13G/A0001104659-24-045323
Feb 8, 2024SC 13G0001104659-24-012374
Jan 31, 202440001415889-24-002062
Jan 24, 202430001415889-24-001783
Feb 16, 202130001104659-21-024391
Feb 16, 2021SC 13D0001104659-21-024389
Dec 15, 2020D0001834150-20-000002